                        RECOMMENDED FOR FULL-TEXT PUBLICATION
                            Pursuant to Sixth Circuit I.O.P. 32.1(b)
                                   File Name: 19a0115p.06

                 UNITED STATES COURT OF APPEALS
                               FOR THE SIXTH CIRCUIT



 JOHN DOE,                                             ┐
                                Plaintiff-Appellant,   │
                                                       │
                                                       >      No. 18-5897
       v.                                              │
                                                       │
                                                       │
 BLUECROSS BLUESHIELD OF TENNESSEE, INC.,              │
                             Defendant-Appellee.       │
                                                       ┘

                       Appeal from the United States District Court
                   for the Western District of Tennessee at Memphis.
                  No. 2:17-cv-02793—Thomas L. Parker, District Judge.

                                  Argued: May 1, 2019

                             Decided and Filed: June 4, 2019

              Before: GUY, SUTTON, and NALBANDIAN, Circuit Judges.
                               _________________

                                       COUNSEL

ARGUED: Jerry Flanagan, CONSUMER WATCHDOG, Los Angeles, California, for
Appellant. Todd Kim, REED SMITH LLP, Washington, D.C., for Appellee. ON BRIEF: Jerry
Flanagan, CONSUMER WATCHDOG, Los Angeles, California, Edith M. Kallas, WHATLEY
KALLAS, LLP, New York, New York, Alan M. Mansfield, WHATLEY KALLAS, LLP, San
Diego, California, Jerry Martin, Seth M. Hyatt, BARRETT JOHNSTON MARTIN &
GARRISON, LLC, Nashville, Tennessee, for Appellant. Todd Kim, REED SMITH LLP,
Washington, D.C., Bryan M. Webster, Abraham Judson Souza, REED SMITH LLP, Chicago,
Illinois, for Appellee.
 No. 18-5897                  Doe v. BlueCross BlueShield of Tenn., Inc.                   Page 2


                                       _________________

                                             OPINION
                                       _________________

       SUTTON, Circuit Judge. Treating similarly situated people differently goes to the heart
of invidious discrimination. But treating differently situated people differently usually counts as
equal justice under law.     Today’s case involves the second scenario in the context of an
application of the antidiscrimination provisions of the Affordable Care Act.

       John Doe receives HIV medicine through a health care plan administered by BlueCross
BlueShield of Tennessee.      Although Doe would like to pick up his medicine at his local
pharmacy, his plan requires him, and anyone else who uses certain high-cost drugs, to get his
medicine by mail or at a specialty pharmacy.          Frustrated by that requirement, Doe sued
BlueCross for discriminating against him on the basis of disability and for breaching their
contract. The district court rejected the claims as a matter of law. We affirm.

                                                 I.

       John Doe is HIV-positive and takes Genvoya to keep his condition under control. While
advances in HIV/AIDS research continue to improve treatment for the disease, the most effective
medicines can be expensive. Doe receives health insurance from BlueCross. Happily for him,
the plan covers Genvoya.

       Unhappily for him, BlueCross imposes requirements on where individuals obtain the
medication. Doe originally bought Genvoya from his local pharmacy. But after February 2017,
the pharmacy told him that BlueCross wouldn’t pay for the medication there any longer.
BlueCross requires beneficiaries to obtain specialty medicines—usually high-cost medicines for
chronic and serious diseases—from a specialty pharmacy network if they want to pay in-network
(read lower) prices. That meant Doe could fill the HIV prescription only through mail order or
by picking it up at certain brick-and-mortar pharmacies. So long as Doe used the specialty
pharmacy network, his co-pay for each monthly batch of Genvoya would be $120. But if Doe
continued to get the medicine at his local pharmacy, BlueCross wouldn’t cover it at all, leaving
him to pay full freight at thousands of dollars per batch.
 No. 18-5897                     Doe v. BlueCross BlueShield of Tenn., Inc.                Page 3


       This development bothered Doe. He liked interacting with his regular pharmacists, who
knew his medical history and who could spot the effects of harmful drug interactions. He also
worried that medicine deliveries to his house might compromise his privacy or risk heat damage
to the medicine. Doe asked BlueCross for permission to opt out of the specialty medications
program. BlueCross declined.

       Doe filed this putative class action against BlueCross, alleging that it discriminated
against him and other HIV-positive beneficiaries in violation of the Affordable Care Act as well
as the Americans with Disabilities Act and that it breached their insurance contract. The district
court granted BlueCross’s motion to dismiss the complaint and denied Doe leave to amend.

                                                  II.

       The Affordable Care Act claim. Doe contends that BlueCross discriminated against him
on the basis of disability in violation of § 1557 of the Patient Protection and Affordable Care
Act. The argument implicates two questions. Does the standard of liability include a relaxed
form of disparate-impact discrimination? May Doe bring a private lawsuit to enforce the claim?

       As for the standard of liability, the language of the statute is a good place to start. The
first sentence of § 1557 provides that “an individual shall not, on the ground prohibited under
title VI of the Civil Rights Act of 1964, title IX of the Education Amendments of 1972, the Age
Discrimination Act of 1975, or section 504 of the Rehabilitation Act of 1973, be excluded from
participation in, be denied the benefits of, or be subjected to discrimination under, any health
program or activity, any part of which is receiving Federal financial assistance.” 42 U.S.C.
§ 18116(a).    This language brings the problem into view.          Doe thinks that some of the
incorporated statutes permit discrimination claims based on a relaxed disparate-impact theory of
liability and that some of them do not. As he sees it, he may pick the statute with the lightest
standard from this menu of four options and use that standard of liability in prosecuting his claim
for disability discrimination.

       The statute does not permit this reading. In the abstract, the word “ground” picks up the
basis on which the insurer takes an action. See 6 Oxford English Dictionary 876 (2d ed. 1989).
In the concrete context of this law, the word “ground” refers to the forbidden source of
 No. 18-5897                 Doe v. BlueCross BlueShield of Tenn., Inc.                     Page 4


discrimination:   race, color, and national origin (Title VI); sex (Title IX); age (Age
Discrimination Act); and disability (Rehabilitation Act).        When “ground” is paired with
“prohibited,” as in “on the ground prohibited,” the statute picks up the type of discrimination—
the standard for determining discrimination—prohibited under each of the four incorporated
statutes. If the claimant seeks relief for discrimination “on the ground prohibited” by § 504 of
the Rehabilitation Act, for example, he must show differential treatment “solely by reason of”
disability, 29 U.S.C. § 794(a), not some other standard of care.          See Lewis v. Humboldt
Acquisition Corp., 681 F.3d 312, 315–16 (6th Cir. 2012) (en banc). Otherwise, the health
insurer’s actions do not amount to the kind of “discrimination” barred by the law.

       Think of it this way. The Affordable Care Act prohibits discrimination based on several
grounds. But it does not change the nature of those grounds any more than it adds a new form of
discrimination, say discrimination based on political perspective, to the law. By referring to four
statutes, Congress incorporated the legal standards that define discrimination under each one.
See Panama R. Co. v. Johnson, 264 U.S. 375, 392 (1924).

       The second sentence of the section reinforces this conclusion.           It says that “[t]he
enforcement mechanisms provided for and available under such title VI, title IX, section 504, or
such Age Discrimination Act shall apply for purposes of violations of this subsection.”
42 U.S.C. § 18116(a). “Enforcement” refers to compelling adherence to the duty in each law.
5 Oxford English Dictionary, supra, at 245. And a “mechanism” is the means of producing each
end. 9 id. at 536. The phrase “enforcement mechanism” thus covers the distinct methods
available under the four listed statutes for compelling compliance with the substantive
requirements of each statute. If the first sentence created a brand-new single standard for what
qualifies as discrimination, why would Congress use four distinct families of enforcement
mechanisms to compel compliance with that standard rather than creating a matching single
mechanism? We can think of no answer. Here, as is so often the case, Occam’s Razor provides
a handy guide.

       Pulling all of this together, the statute prohibits discrimination against the disabled in the
provision of federally supported health programs under § 504 of the Rehabilitation Act. In doing
 No. 18-5897                  Doe v. BlueCross BlueShield of Tenn., Inc.                     Page 5


so, the Affordable Care Act picks up the standard of care for showing a violation of § 504, not
the other laws incorporated by the statute or for that matter any other statute.

       This approach also makes short work of the second statutory question: May Doe enforce
the law through a private right of action? Yes. Because the Rehabilitation Act contains a private
right of action, see Barnes v. Gorman, 536 U.S. 181, 185 (2002), the enforcement mechanism
sentence permits Doe to bring this lawsuit to enforce that prohibition under the Affordable Care
Act as well.

       Doe accepts some of this analysis. He agrees that the Act gives him a private cause of
action to sue for disability discrimination for the reasons just given.            But he thinks the
enforcement mechanism sentence allows him to use any of the four substantive legal standards
for proving discrimination and apply it to any of the four classifications.

       Picking your own adventure, however, is not what that sentence says. The phrase
“enforcement mechanism” refers to the process for compelling compliance with a substantive
right, not the substantive right itself. As we have said before, in interpreting § 504 of the
Rehabilitation Act no less, “[e]nforcement provisions generally do not alter substantive standards
of care.” Lewis, 681 F.3d at 316. Had Congress wished to make all of the enforcement
mechanisms available for any classification, it would have said “[t]he enforcement mechanisms
provided for and available under title VI, title IX, section 504, and such Age Discrimination Act
shall apply”—instead of the or it opted to use.

       Context does Doe’s argument no favors either. Each antidiscrimination statute has its
own highly reticulated set of enforcement rules adapted for the type of discrimination that each
law targets.   For example, Title VI, Title IX, and § 504 do not require the exhaustion of
administrative remedies before bringing a private cause of action, while the Age Discrimination
Act does. See 42 U.S.C. § 6104(e)(2), (f) (Age Discrimination Act); Cannon v. Univ. of Chi.,
441 U.S. 677, 706 n.41 (1979) (Title IX); Tuck v. HCA Health Servs. of Tenn., Inc., 7 F.3d 465,
470–71 (6th Cir. 1993) (§ 504); Neighborhood Action Coal. v. City of Canton, 882 F.2d 1012,
1015 (6th Cir. 1989) (Title VI). And while Title VI, Title IX, and § 504 allow the recovery of
compensatory damages, the Age Discrimination Act does not.               See 42 U.S.C. § 6104(e)
 No. 18-5897                   Doe v. BlueCross BlueShield of Tenn., Inc.                   Page 6


(Age Discrimination Act); Barnes, 536 U.S. at 185–89 (Title VI, Title IX, and § 504). Allowing
plaintiffs to treat all of this as a use-what-you-wish buffet would make a hash of the underlying
enforcement schemes.

         Despite each of the problems with his interpretation, Doe thinks he has an ace in the hole:
a helpful agency interpretation. Yes, the Department of Health and Human Services’ Office for
Civil Rights supports his view. During the notice-and-comment process for promulgating the
§ 1557 regulations, commenters asked the agency to clarify whether the enforcement
mechanisms of each statute, including disparate-impact discrimination as a basis for liability, are
available to any plaintiff regardless of the nature of the discrimination at issue. The agency
responded that it “interprets Section 1557 as authorizing a private right of action for claims of
disparate impact discrimination on the basis of any of the criteria enumerated in the legislation.”
Nondiscrimination in Health Programs and Activities, 81 Fed. Reg. 31,376, 31,439–40 (May 18,
2016).

         But this interpretive guidance does not do everything Doe thinks it does. While agencies
may have authority to interpret statutes, they do not have authority to rewrite them. “If the intent
of Congress is clear, that is the end of the matter.” Chevron U.S.A., Inc. v. Nat. Res. Def.
Council, Inc., 467 U.S. 837, 842 (1984). In § 1557, as just shown, Congress made plain that it
prohibited discrimination in the provision of health care by incorporating and enforcing the
substantive standards of liability of the four named statutes, not changing them. There is just one
permissible interpretation of this language, and the agency failed to respect it. Its contrary
agency interpretation counts for naught.

         One last point deserves mention. It’s not clear that Doe’s interpretation of the statute
would help him anyway.         He thinks that some of the antidiscrimination statutes prohibit
disparate-impact discrimination, and that § 1557 leaves him free to pick that standard of liability
and apply it to his disability-discrimination claim. But Doe, like the agency, may have a
misunderstanding about how each statute works.           Title VI, for example, doesn’t prohibit
disparate-impact discrimination. See Alexander v. Sandoval, 532 U.S. 275, 280 (2001). It’s
unlikely that Title IX, which was patterned on Title VI, does so either.           See Jackson v.
Birmingham Bd. of Educ., 544 U.S. 167, 173 (2005) (“Title IX implies a private right of action to
 No. 18-5897                  Doe v. BlueCross BlueShield of Tenn., Inc.                     Page 7


enforce its prohibition on intentional sex discrimination.”); Sandoval, 532 U.S. at 280; Cannon,
441 U.S. at 695–96. And contrary to the agency’s understanding, see 81 Fed. Reg. at 31,439,
there is no reason to think the Age Discrimination Act of 1975 picks up this standard of liability,
see Kamps v. Baylor Univ., 592 F. App’x 282, 285–86 (5th Cir. 2014). The Age Discrimination
in Employment Act of 1967, it is true, prohibits disparate-impact discrimination. See Smith v.
City of Jackson, 544 U.S. 228, 233–40 (2005). But unlike that statute, the 1975 Age Act does
not bar practices that “otherwise adversely affect” people because of their age, making any
analogy (or conflation) between the two laws dubious. See Kamps, 592 F. App’x at 285–86.
That leaves the legal standard of the Rehabilitation Act as Doe’s best shot, which is exactly what
he gets under our reading of the statute.

       Application of the Rehabilitation Act. Section 504 of the Rehabilitation Act of 1973
provides that “[n]o otherwise qualified individual with a disability in the United States . . . shall,
solely by reason of her or his disability, be excluded from the participation in, be denied the
benefits of, or be subjected to discrimination under any program or activity receiving Federal
financial assistance.” 29 U.S.C. § 794(a). To state a claim under the Rehabilitation Act, as
incorporated into the Affordable Care Act, Doe thus must allege that (1) he is an individual with
a disability; (2) he is otherwise qualified for participation in a health program or activity; (3) he
is being excluded from participation in, denied the benefits of, or subjected to discrimination
under the program solely by reason of his disability; and (4) the program receives federal
assistance. See Maddox v. Univ. of Tenn., 62 F.3d 843, 846 (6th Cir. 1995).

       We take a few things for granted—that Doe’s HIV-positive status counts as a disability
under the Act, that he is otherwise qualified for his benefits plan, and that the plan receives
federal funds. Even then, has Doe been excluded from participation in, denied the benefits of, or
subjected to discrimination under his plan?

       No, we must conclude. BlueCross did not exclude Doe from participating in the plan or
deny him benefits covered by it, as he seems to concede. And contrary to his argument, the
plan’s specialty medications program did not discriminate against him based on disability.
 No. 18-5897                  Doe v. BlueCross BlueShield of Tenn., Inc.                   Page 8


       Doe cannot show that BlueCross intentionally discriminated against him. The plan’s
specialty medications list is neutral on its face. Some of the included medicines are apt to be
used by those with disabilities. But plenty of others are not, such as medicines used to treat high
cholesterol, osteoporosis, or allergic rhinitis, sometimes called a runny nose. See 29 U.S.C.
§ 705(20)(B); 42 U.S.C. § 12102(1) (defining a disability as an impairment that substantially
limits one or more major life activities). The common trait linking the listed drugs is cost, not
the disabled status of their users.     Because the specialty medications program does not
distinguish based on disability, much less “solely” so, it does not convey any discriminatory
intent. See Jones v. City of Monroe, 341 F.3d 474, 478 (6th Cir. 2003).

       Doe argues that, even if the plan doesn’t intentionally discriminate against the disabled, it
causes a cognizable disparate impact. This raises an open question about the scope of the
Rehabilitation Act, one we close today. In Alexander v. Choate, the Supreme Court rejected the
“boundless notion” that all disparate-impact showings establish a prima facie case under § 504.
469 U.S. 287, 299 (1985). But it “assume[d] without deciding that § 504 reaches at least some
conduct that has an unjustifiable disparate impact upon the handicapped.” Id.

       We now resolve what Choate did not and conclude that § 504 does not prohibit
disparate-impact discrimination.

       Take the text.     Disparate-impact discrimination occurs when an entity acts for a
nondiscriminatory reason but nevertheless disproportionately harms a protected group. See Ricci
v. DeStefano, 557 U.S. 557, 577 (2009). But the Rehabilitation Act bars discrimination “solely
by reason of her or his disability.” 29 U.S.C. § 794(a); see Lewis, 681 F.3d at 315–17. That
language does not encompass actions taken for nondiscriminatory reasons. The language, as
well, applies only to individuals who are “otherwise qualified” for the program at issue, meaning
that the Act allows the disabled to be “disparately affected by legitimate job criteria.” Crocker v.
Runyon, 207 F.3d 314, 321 (6th Cir. 2000). All of this explains why we have remarked that
“[t]here is good reason to believe that a disparate impact theory is not available under the
Rehabilitation Act.” Id. We agree, and so hold.
 No. 18-5897                  Doe v. BlueCross BlueShield of Tenn., Inc.                     Page 9


       A comparison to other antidiscrimination statutes leads to the same conclusion.
Section 504 “was patterned after Title VI.” Cmty. Television of S. Cal. v. Gottfried, 459 U.S.
498, 509 (1983).      Like § 504, Title VI prohibits a person from “be[ing] excluded from
participation in, be[ing] denied the benefits of, or be[ing] subjected to discrimination” on the
basis of a protected classification.      42 U.S.C. § 2000d.       And Title VI does not reach
disparate-impact discrimination. See Sandoval, 532 U.S. at 280–81. By contrast, when the
Court has found that a statute prohibits disparate-impact discrimination, it has relied on language
like “otherwise adversely affect” or “otherwise make unavailable,” which refers to the
consequences of an action rather than the actor’s intent. See Tex. Dep’t of Hous. & Cmty. Affairs
v. Inclusive Cmtys. Project, Inc., 135 S. Ct. 2507, 2518–19 (2015) (Fair Housing Act); Smith,
544 U.S. at 235–36 (1967 Age Act); Griggs v. Duke Power Co., 401 U.S. 424, 429–31 (1971)
(Title VII). That language is missing from § 504, just as it is missing from Title VI.

       The oddity of applying disparate-impact discrimination in this area points in the same
direction. Because many neutral (and well-intentioned) policies disparately affect the disabled—
the point of such laws most often is to ease the burden of having a disability—the proposed use
of the theory under § 504 “could lead to a wholly unwieldy administrative and adjudicative
burden.” Choate, 469 U.S. at 298. With thirty years of hindsight, we can go one step further.
Even entertaining the idea of disparate-impact liability in this area invites fruitless challenges to
legitimate, and utterly nondiscriminatory, distinctions, as this case aptly shows.

       Perhaps, one might argue, the Court’s assumption in Choate should count as something
more. After all, at the same time the Court recognized that § 504 “was patterned after and is
almost identical to” Title VI, it also said that “too facile an assimilation of Title VI law to § 504
must be resisted.” Id. at 293 n.7. It then chose to “assume without deciding” that § 504 means
something different than its twin. See id. at 299. But the Court’s words of caution about the
relationship between the two statutes do not foreclose our own analysis. The key word is
“assume.”    Because Choate did not decide the issue either way, and in fact expressed
reservations about the effects of disparate-impact liability in this area, we remain free to hold that
§ 504 does not cover disparate-impact claims.
 No. 18-5897                  Doe v. BlueCross BlueShield of Tenn., Inc.                  Page 10


       Other courts of appeals, we realize, have made the same assumption that Choate did.
See, e.g., Ruskai v. Pistole, 775 F.3d 61, 78 (1st Cir. 2014); CG v. Pa. Dep’t of Educ., 734 F.3d
229, 236 (3d Cir. 2013); Berg v. Fla. Dep’t of Labor & Emp’t Sec., Div. of Vocational Rehab.,
163 F.3d 1251, 1254 (11th Cir. 1998). And indeed at least two have acted on it. See McWright
v. Alexander, 982 F.2d 222, 228–29 (7th Cir. 1992); Robinson v. Kansas, 295 F.3d 1183, 1187
(10th Cir. 2002).     But in recognizing disparate-impact claims, the cases overlooked the
“essentially identical” text of Title VI and § 504, elevating the purpose of § 504 in light of the
“different aim of the Rehabilitation Act as well as the different context in which the Act was
passed.” Robinson, 295 F.3d at 1187. Even assuming these cases correctly describe the purpose
of the Act, “[n]o legislation pursues its purposes at all costs.” Pension Benefit Guar. Corp. v.
LTV Corp., 496 U.S. 633, 646 (1990) (quotation omitted). By any conventional measure, the
text leaves no room for the statute to prohibit disparate-impact discrimination.

       Doe tries to counter this conclusion on two main grounds. He says that BlueCross’s
inclusion of some drugs used by the non-disabled on the specialty medications list was a pretext
to cover its intentional discrimination against those with disabilities. But why that is so is never
explained. The reality remains that this lengthy list treats the disabled and non-disabled alike,
removing any possibility that BlueCross targeted individuals with disabilities. Jones, 341 F.3d at
478.

       Doe also argues that BlueCross wrongfully denied his request for an accommodation,
namely letting him buy the medicine at his local pharmacy. A claim based on a denial of a
reasonable accommodation differs from a disparate-impact claim. See Ability Ctr. of Greater
Toledo v. City of Sandusky, 385 F.3d 901, 904 n.4 (6th Cir. 2004); Henrietta D. v. Bloomberg,
331 F.3d 261, 276–77 (2d Cir. 2003); see also Lee v. City of Los Angeles, 250 F.3d 668, 690–91
(9th Cir. 2001). Under the Rehabilitation Act, a disabled person is “otherwise qualified” for a
program if he could meet its requirements with a reasonable accommodation. See Kaltenberger
v. Ohio Coll. of Podiatric Med., 162 F.3d 432, 435 (6th Cir. 1998); see also 29 U.S.C. § 794(d);
28 C.F.R. § 41.53. And when that holds true, a denial of the requested accommodation may
amount to unlawful discrimination. See Kaltenberger, 162 F.3d at 435–36. But that distinction
 No. 18-5897                 Doe v. BlueCross BlueShield of Tenn., Inc.                 Page 11


does not help Doe. He forfeited his reasonable accommodation argument by failing to articulate
it below. See Doe v. Miami Univ., 882 F.3d 579, 594–95 (6th Cir. 2018).

       The Americans with Disabilities Act claim.       Doe separately claims that BlueCross
discriminated against him in violation of Title III of the Americans with Disabilities Act. The
nature of the claim—that BlueCross discriminated against his use of a public accommodation,
the local pharmacy—has a familiar ring to it. And so, regrettably for him, does our conclusion.

       The Americans with Disabilities Act prohibits disability discrimination in the enjoyment
of public accommodations “by any person who owns, leases (or leases to), or operates a place of
public accommodation.” 42 U.S.C. § 12182(a). A pharmacy counts as a public accommodation.
Id. § 12181(7)(F).

       Because BlueCross doesn’t own, lease, or operate Doe’s local pharmacy, his claim fails.
Everyone agrees that BlueCross doesn’t own or lease the pharmacy. And all dictionaries agree
in one way or another that the word “operate” means “[t]o direct the working of; to manage,
conduct, work (a railway, business, etc.).” 10 Oxford English Dictionary, supra, at 848; see Neff
v. Am. Dairy Queen Corp., 58 F.3d 1063, 1066 (5th Cir. 1995).

       BlueCross doesn’t operate Doe’s local pharmacy in any meaningful sense of the word.
BlueCross does not control the pharmacy’s hours, accessibility policies, or customer service
protocols. It controls just one thing related to the pharmacy: how much Doe pays out-of-pocket
for a product he would like to purchase there. That type of arrangement doesn’t make BlueCross
the pharmacy’s manager.

       Doe insists otherwise, noting the connection between the specialty medications program
and his diminished access to medicine. Yes, BlueCross may in one sense be responsible for
denying him in-network benefits at the pharmacy.        The same, however, could be said of
Congress, which wrote the Americans with Disabilities Act and which in another sense is
responsible for BlueCross not having to make this accommodation. But neither of these things
makes them managers of the pharmacy. The truth of the matter is that Doe targets BlueCross’s
operation of his health care plan, not its control over his pharmacy. And Doe’s health plan
 No. 18-5897                 Doe v. BlueCross BlueShield of Tenn., Inc.                 Page 12


simply does not qualify as a public accommodation. See Parker v. Metro. Life Ins. Co., 121 F.3d
1006, 1014 (6th Cir. 1997) (en banc).

       The breach of contract claim. Doe alleges that BlueCross breached its contract with him
by violating its implied duty of good faith and fair dealing. Tennessee law, it is true, imposes a
duty of good faith in the performance of contracts. Dick Broad. Co. of Tenn. v. Oak Ridge FM,
Inc., 395 S.W.3d 653, 660 (Tenn. 2013). But as Doe seems to concede, the failure of his
Affordable Care Act and Americans with Disabilities Act claims dooms his argument that
BlueCross violated its duty of good faith by inadequately covering his Genvoya. Doe’s contract
claim does not get off the ground.

       The motion for leave to amend. Doe ends by arguing that the district court should have
let him amend his complaint a second time. But in his request for leave to amend, Doe did not
explain to the district court how he intended to patch up his complaint. On appeal, he has
provided a few hints about amendments he would like to make, but they would still leave his
complaint inadequate. A court need not grant leave to amend when doing so would be futile.
See Beydoun v. Sessions, 871 F.3d 459, 469 (6th Cir. 2017).

       We affirm.
